HUM.NYSEHumana INC

Form 4: Humana Inc. Executive John-Paul W. Felter Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


John-Paul W. Felter, SVP, Chief Accounting Officer & Controller of Humana Inc., reports acquisition and disposal of Humana common stock and restricted stock units.

Summary

  • On February 24, 2025, John-Paul W. Felter, a Senior Vice President, Chief Accounting Officer & Controller at Humana Inc., reported transactions involving Humana common stock and restricted stock units.
  • Felter acquired 876 shares of Humana common stock.
  • Felter disposed of 0 shares of Humana common stock at $0.
  • Following the reported transactions, Felter beneficially owns 1,767 shares of Humana common stock.
  • The report also details holdings of restricted stock units, which convert to Humana common stock.
  • Some restricted stock units were granted on August 1, 2022, vesting in installments on August 1, 2023, August 1, 2024, and August 1, 2025.
  • Other restricted stock units were granted on February 24, 2023, vesting in installments on December 15, 2023, December 15, 2024, and December 15, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of shares by an executive is mildly positive, suggesting confidence, but it's not a major event.

Positives

  • The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

  • Executive stock ownership is a common practice across publicly traded companies, particularly in the healthcare sector.
  • Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have similar reporting requirements for their executives' stock transactions.
  • The vesting schedules for restricted stock units are fairly standard, typically ranging from three to five years.

Stakeholder Impact

  • Shareholders may view the executive's stock acquisition as a positive sign of confidence in the company's performance.

Key Dates

DateDescription
08/01/2022Restricted stock units granted to reporting person, vesting in installments.
02/24/2023Restricted stock units granted to reporting person, vesting in installments.
08/01/202333% of restricted stock units granted on 8/1/2022 vesting date.
12/15/202333% of restricted stock units granted on 2/24/2023 vesting date.
08/01/202433% of restricted stock units granted on 8/1/2022 vesting date.
12/15/202433% of restricted stock units granted on 2/24/2023 vesting date.
02/24/2025Date of the reported stock transaction.
08/01/202533% of restricted stock units granted on 8/1/2022 vesting date.
12/15/202533% of restricted stock units granted on 2/24/2023 vesting date.
02/26/2025Date of signature for the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.